About: Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2000 (uk) article scientifique publié en 2000 (fr) im August 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 2000 (ast) scientific article published on 01 August 2000 (en)
publication date	wds:Q74128888-02695558-028D-4EF7-9523-2BD81B78D0F2
publication date	2000-08-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q74128888-1802CFC4-78BB-49D7-8067-745ADAF1590D wds:Q74128888-5DC26589-FC44-43E7-9385-45C894B4F3B8 wds:Q74128888-9689383A-AB4C-4815-9E82-EB39C47C916D wds:Q74128888-A2D18BCF-22E0-4572-B163-35CA6A7CFA9B
author name string	R A Mathôt P G Mulder C B Lamers W P Geus
rdfs:label	Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects (en) Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects (nl)
skos:prefLabel	Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects (en) Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects (nl)
name	Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects (en) Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects (nl)
title	wds:Q74128888-1E4F77F0-8635-4E11-A0D1-221DC84C069B
title	Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects (en)
page(s)	wds:Q74128888-2B2247D5-0975-42D3-A8F8-0F6AFACD9F92
page(s)	1057-1064
instance of	wds:Q74128888-39CFDED7-AC0A-4A5E-AA0B-D5465DD5099F
instance of	scholarly article
main subject	wds:Q74128888-430D2163-9306-4979-B803-2C744DA35676 wds:Q74128888-8EEA1545-D266-40E2-9F7D-05879F0471B9
main subject	Helicobacter pylori omeprazole
PubMed ID	wds:Q74128888-22BDECA5-39BF-4C7D-AF19-ADF691186881
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10930900
PubMed ID	10930900
published in	wds:Q74128888-C2698076-3147-43A6-B01D-5DA68B4BDC5D
published in	Alimentary Pharmacology & Therapeutics
issue	wds:Q74128888-B9EB2DAF-FA07-4462-A23F-9956A00E31D1
volume	wds:Q74128888-63FAE893-9EF7-4BC9-B33C-51BE227BF52C
issue	8
volume	14
DOI	wds:Q74128888-B5A4ED4E-B72F-452D-B19C-153609567BB3
DOI	http://dx.doi.org/10.1046/J.1365-2036.2000.00806.X
DOI	10.1046/J.1365-2036.2000.00806.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74128888
is cites work of	Fosamprenavir : clinical pharmacokinetics and drug interactions of the amprenavir prodrug Effect of CYP2C192 and 17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH. Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know Proton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cells. Possible interethnic differences in omeprazole pharmacokinetics : comparison of Jordanian Arabs with other populations Formulation of Broccoli Sprout Powder in Gastro-Resistant Capsules Protects against the Acidic pH of the Stomach In Vitro but Does Not Increase Isothiocyanate Bioavailability In Vivo
is cites work of	wds:Q36729180-0BBF75FF-685F-4F28-9259-3A4A6B01F13D wds:Q83830606-27C07A21-6043-4B4C-9CBD-B1FC2C03FB89 wds:Q93080625-33C5A79D-F6A5-4B15-A55F-506A351413DD wds:Q36399718-C889D79D-6AC3-4143-8F40-AEAB24E0FE74 wds:Q37299839-C2EAFE29-972F-49C9-83CF-F347A70850A1 wds:Q35603768-4B86D52B-8368-4D3B-968C-D3FB6B3113C2 wds:Q35028387-843F17DC-233E-45C6-AA45-D517A5BCE5E1 wds:Q54470777-9C00250F-B5B8-48D8-9E75-6F328E6AFEAB

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software